|
IL112372A
(en)
|
1994-02-07 |
2001-08-26 |
Res Dev Foundation |
Non-viral vector for the delivery of genetic information to cells
|
|
NZ304715A
(en)
|
1995-03-22 |
1999-07-29 |
Jackson H M Found Military Med |
Production of immunogenic constructs using organic cyanylating reagents to activate carbohydrates and then coupling the carbohydrate to a protein, peptide or hapten
|
|
JP4469026B2
(ja)
|
1996-10-31 |
2010-05-26 |
ヒューマン ジノーム サイエンシーズ，インコーポレイテッド |
Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｎｅｕｍｏｎｉａｅの抗原およびワクチン
|
|
EP0977588B1
(en)
|
1997-04-24 |
2004-10-06 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines
|
|
US7060458B1
(en)
|
1997-08-14 |
2006-06-13 |
Wyeth |
Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
|
|
WO1999012416A1
(en)
|
1997-09-09 |
1999-03-18 |
The Trustees Of Columbia University In The City Of New York |
T-independent conjugate-vaccines
|
|
CN1318103A
(zh)
*
|
1998-07-27 |
2001-10-17 |
微生物技术有限公司 |
肺炎链球菌的核酸和蛋白质
|
|
US8246945B2
(en)
|
2000-04-06 |
2012-08-21 |
University Of Arkansas |
Methods and reagents for decreasing clinical reaction to allergy
|
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
|
NZ536859A
(en)
|
2002-05-14 |
2007-11-30 |
Chiron Srl |
Mucosal combination vaccines for bacterial meningitis
|
|
US20060251675A1
(en)
|
2003-03-17 |
2006-11-09 |
Michael Hagen |
Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
|
|
EP2311988A1
(en)
|
2003-04-15 |
2011-04-20 |
Intercell AG |
S. pneumoniae antigens
|
|
BRPI0410423A
(pt)
|
2003-05-07 |
2006-06-06 |
Sanofi Pasteur Inc |
processo de imunogenicidade melhorada para vacinação meningocócica
|
|
CA2537900A1
(en)
|
2003-09-03 |
2005-04-28 |
Dendritherapeutics, Inc. |
Multiplex vaccines
|
|
US20050112139A1
(en)
|
2003-10-23 |
2005-05-26 |
Nmk Research, Llc |
Immunogenic composition and method of developing a vaccine based on factor H binding sites
|
|
US20070128183A1
(en)
|
2004-04-27 |
2007-06-07 |
Intercell Ag |
Td antigens
|
|
GB0410220D0
(en)
|
2004-05-07 |
2004-06-09 |
Kirkham Lea Ann |
Mutant pneumolysin proteins
|
|
EP1791961B1
(en)
|
2004-08-18 |
2011-06-08 |
The Governors of the University of Alberta |
Protein production method utilizing yebf
|
|
FI20041396A0
(fi)
|
2004-10-29 |
2004-10-29 |
Vesa Pekka Hytoenen |
Uudet mikrobiavidiinit
|
|
GB0428394D0
(en)
|
2004-12-24 |
2005-02-02 |
Chiron Srl |
Saccharide conjugate vaccines
|
|
WO2006084467A1
(en)
|
2005-02-11 |
2006-08-17 |
Ace Biosciences A/S |
Surface-located streptococcus pneumoniae polypeptides
|
|
US20090148894A1
(en)
|
2005-08-15 |
2009-06-11 |
Broedel Sheldon E |
Methods for optimizing the secretion of protein in prokaryotes
|
|
JP5135220B2
(ja)
|
2005-09-01 |
2013-02-06 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー |
血清群ｃ髄膜炎菌を含む複数ワクチン接種
|
|
EP1957541A2
(en)
*
|
2005-11-21 |
2008-08-20 |
Laboratoires Serono SA |
Compositions and methods of producing hybrid antigen binding molecules and uses thereof
|
|
MX2008007292A
(es)
|
2005-12-08 |
2008-10-17 |
Univ Louisville Res Found |
Composiciones inmunoestimuladoras y metodos.
|
|
WO2007081583A2
(en)
|
2006-01-04 |
2007-07-19 |
Children's Medical Center Corporation |
Anti-pneumococcal preparations and methods of use
|
|
US7943133B2
(en)
|
2006-02-02 |
2011-05-17 |
Boston Biocom Llc |
Mesothelin antibody protein fusions and methods of use
|
|
US20080032340A1
(en)
|
2006-06-09 |
2008-02-07 |
University Of Arizona |
Peptide motifs for binding avidin or neutravidin
|
|
US8148084B2
(en)
|
2006-06-22 |
2012-04-03 |
Dana-Farber Cancer Institute, Inc. |
Diagnosis of autoimmune disease
|
|
CA2690973A1
(en)
|
2006-06-23 |
2007-12-27 |
Paul M. Simon |
Targeted immune conjugates
|
|
US7452985B2
(en)
|
2006-08-17 |
2008-11-18 |
Visgeneer, Inc. |
Human Ron-related gene variant associated with cancers
|
|
WO2008152448A2
(en)
|
2006-12-21 |
2008-12-18 |
Emergent Product Development Uk Limited |
Streptococcus proteins, and their use in vaccination
|
|
CN100579152C
(zh)
|
2007-01-29 |
2010-01-06 |
华为技术有限公司 |
一种播放集团彩铃的方法、系统及装置
|
|
EP2468869B1
(en)
|
2007-01-31 |
2015-03-18 |
Pfenex Inc. |
Bacterial leader sequences for increased expression
|
|
AU2008287286B2
(en)
|
2007-04-13 |
2013-10-10 |
The Board Of Regents Of The University Of Oklahoma |
Mutants of cholesterol-dependent cytolysins and uses thereof
|
|
CA2690708A1
(en)
|
2007-06-26 |
2008-12-31 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
|
WO2009021548A1
(en)
|
2007-08-10 |
2009-02-19 |
Wacker Chemie Ag |
Expression of full length igg and secretion into the culture medium of prokaryotic cells
|
|
JP5658564B2
(ja)
|
2007-08-31 |
2015-01-28 |
ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ |
ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物
|
|
MX2011006922A
(es)
|
2008-12-24 |
2012-06-12 |
Netherlands Vaccine Inst |
Polipeptidos de neumolisina (ply) modificada a partir de streptococcus pneumonia.
|
|
EP2208787A1
(en)
|
2009-01-19 |
2010-07-21 |
Université de Liège |
A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
|
|
EP3263128A3
(en)
|
2009-04-14 |
2018-01-24 |
GlaxoSmithKline Biologicals S.A. |
Compositions for immunising against staphylococcus aureus
|
|
US8828953B2
(en)
|
2009-04-20 |
2014-09-09 |
NaZura BioHealth, Inc. |
Chemosensory receptor ligand-based therapies
|
|
RU2580299C2
(ru)
|
2009-06-29 |
2016-04-10 |
Дженосеа Биосайенсиз, Инк. |
Вакцины и композиции, направленные против streptococcus pneumoniae
|
|
CN101797381B
(zh)
|
2010-01-29 |
2012-05-23 |
中国人民解放军第三军医大学 |
乙肝病毒抗原与路易斯寡糖的复合物及其制备方法和应用
|
|
EP2563396A2
(en)
|
2010-04-30 |
2013-03-06 |
Augmenta Biologicals LLC |
Delivery proteins
|
|
CN103648489A
(zh)
|
2011-05-11 |
2014-03-19 |
儿童医疗中心有限公司 |
多抗原提呈免疫原性组合物及其方法和用途
|
|
WO2014018904A1
(en)
*
|
2012-07-26 |
2014-01-30 |
Genocea Biosciences, Inc. |
Fused antigen vaccines and compositions against streptococcus pneumoniae
|
|
US11576958B2
(en)
*
|
2013-02-07 |
2023-02-14 |
Children's Medical Center Corporation |
Protein antigens that provide protection against pneumococcal colonization and/or disease
|
|
JP2019524639A
(ja)
*
|
2016-05-04 |
2019-09-05 |
ザ チルドレンズ メディカル センター コーポレーション |
アビジン様タンパク質およびそれらの融合タンパク質を精製する方法
|
|
AU2018243910B2
(en)
|
2017-03-28 |
2025-04-10 |
The Children's Medical Center Corporation |
A multiple antigen presenting system (MAPS)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof
|
|
CN112969474A
(zh)
*
|
2018-09-12 |
2021-06-15 |
艾芬尼维克斯公司 |
多价肺炎球菌疫苗
|